PPIL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.566600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.460200E-01
Normal-vs-Stage2
8.290800E-01
Normal-vs-Stage3
7.169600E-01
Normal-vs-Stage4
4.289800E-01
Stage1-vs-Stage2
6.786400E-01
Stage1-vs-Stage3
9.946200E-01
Stage1-vs-Stage4
1.567590E-01
Stage2-vs-Stage3
7.430000E-01
Stage2-vs-Stage4
5.788300E-02
Stage3-vs-Stage4
3.009200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.698600E-01
Normal-vs-AfricanAmerican
7.123600E-01
Normal-vs-Asian
4.693200E-01
Caucasian-vs-AfricanAmerican
4.873400E-01
Caucasian-vs-Asian
5.126800E-01
AfricanAmerican-vs-Asian
1.782570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.595800E-01
Normal-vs-Female
9.893400E-01
Male-vs-Female
2.048600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.164600E-01
Normal-vs-Age(41-60Yrs)
8.967000E-01
Normal-vs-Age(61-80Yrs)
7.006400E-01
Normal-vs-Age(81-100Yrs)
6.285800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.291600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.807800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.676410E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.086300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.434600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.616500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.557600E-01
Normal-vs-Daily Drinker
2.949200E-01
Normal-vs-Weekly Drinker
8.117000E-01
Normal-vs-Occasional Drinker
5.819400E-01
Normal-vs-Social Drinker
9.281600E-01
Non Drinker-vs-Daily Drinker
2.197400E-01
Non Drinker-vs-Weekly Drinker
7.254400E-01
Non Drinker-vs-Occasional Drinker
6.795800E-02
Non Drinker-vs-Social Drinker
4.891000E-01
Daily Drinker-vs-Weekly Drinker
1.797350E-01
Daily Drinker-vs-Occasional Drinker
3.340400E-03
Daily Drinker-vs-Social Drinker
8.341600E-02
Weekly Drinker-vs-Occasional Drinker
2.137400E-01
Weekly Drinker-vs-Social Drinker
7.842800E-01
Occasional Drinker-vs-Social Drinker
3.115200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.794200E-01
Normal-vs-Grade 2
9.323000E-01
Normal-vs-Grade 3
9.645200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.977800E-01
Grade 1-vs-Grade 3
2.145600E-01
Grade 1-vs-Grade 4
8.794200E-01
Grade 2-vs-Grade 3
5.363000E-01
Grade 2-vs-Grade 4
9.323000E-01
Grade 3-vs-Grade 4
9.645200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.457200E-01
Normal-vs-NonDiabetic
8.143200E-01
Diabetic-vs-NonDiabetic
3.849000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.618300E-02
Normal-vs-NoPancreatitis
8.655000E-01
Pancreatitis-vs-NoPancreatitis
1.583670E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.277200E-01
Normal-vs-N1
8.520200E-01
N0-vs-N1
7.436600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.968400E-01
Normal-vs-TP53-NonMutant
9.111200E-01
TP53-Mutant-vs-TP53-NonMutant
2.133000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
